ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,614Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 2094

$3.14M Total Retail Price of All Prescriptions

Rank: 2 out of 2094

917 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 917 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 917 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 21,280 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

51% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$114 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
CRESTOR 836 717 1 15
ATORVASTATIN CALCIUM 616 504 2 5
BYSTOLIC 615 467 3 83
OMEPRAZOLE 601 452 4 4
LEVOTHYROXINE SODIUM 565 454 5 3
AMLODIPINE BESYLATE 523 428 6 2
BIDIL 521 411 10 7 234
LOVAZA 516 399 8 53
ZOLPIDEM TARTRATE 504 371 9 14
TORSEMIDE 501 424 10 118
LEVOCARNITINE 496 439 10 11 294
CARVEDILOL 467 373 12 19
CLOPIDOGREL 454 383 13 22
DIOVAN 442 368 14 13
ADVAIR DISKUS 431 275 15 36
SPIRIVA 391 254 16 60
METFORMIN HCL 344 265 17 8
NEXIUM 341 259 18 16
PLAVIX 332 280 19 38
NAMENDA 326 323 20 32
AZOR 326 247 20 155
VICTOZA 3-PAK 313 197 10 22 311
GABAPENTIN 304 197 23 23
SIMVASTATIN 298 207 24 1
METFORMIN HCL ER 289 216 25 67
ZEMPLAR 270 234 26 287
LYRICA 245 168 27 85
ONGLYZA 233 182 28 134
FUROSEMIDE 230 187 29 6
TRAMADOL HCL 219 164 30 33
POLYETHYLENE GLYCOL 3350 211 142 31 75
TRADJENTA 196 169 10 32 302
DILTIAZEM 24HR CD 194 171 33 110
WARFARIN SODIUM 194 174 33 11
ATELVIA 194 156 33 135
EXELON 193 193 36 111
LANTUS SOLOSTAR 191 141 37 76
BENICAR 189 154 38 108
PROAIR HFA 188 115 39 45
SINGULAIR 180 115 40 64
EXFORGE 171 156 41 105
JANUVIA 162 112 42 35
UNIFINE PENTIPS 156 117 10 43 257
CHLORTHALIDONE 155 124 44 200
METHYLPREDNISOLONE 154 108 45 127
PREDNISONE 149 97 46 54
DIOVAN HCT 145 97 47 28
ALENDRONATE SODIUM 143 87 48 30
CELEBREX 143 126 48 74
MONTELUKAST SODIUM 142 81 50 128
METOPROLOL TARTRATE 142 113 50 10
CARAFATE 141 103 52 270
METOPROLOL SUCCINATE 139 110 53 9
ENDOCET 138 74 S2 54 88
PANTOPRAZOLE SODIUM 133 118 55 37
LOSARTAN POTASSIUM 132 105 56 17
DIGOXIN 132 122 56 51
FLUOXETINE HCL 130 87 58 139
PRAMIPEXOLE DIHYDROCHLORIDE 128 84 59 250
TRILIPIX 126 92 60 156
TAMSULOSIN HCL 126 110 60 29
PRADAXA 125 110 62 209
NAPROXEN 124 100 63 84
FAMOTIDINE 121 95 64 34
WELCHOL 119 72 65 146
LIPITOR 116 101 66 39
JANUMET 114 81 67 86
AGGRENOX 113 85 68 260
ULORIC 110 95 69 325
PEN NEEDLE 108 82 70 136
CYMBALTA 108 63 70 61
POTASSIUM CHLORIDE 107 76 72 24
AMLODIPINE BESYLATE-BENAZEPRIL 107 96 72 58
LIDODERM 107 94 72 59
AVODART 106 82 75 163
FLUTICASONE PROPIONATE 103 66 76 41
AZITHROMYCIN 103 74 76 27
PRANDIN 98 95 78 125
LISINOPRIL 98 71 78 7
DONEPEZIL HCL 97 94 80 20
SPIRONOLACTONE 97 73 80 93
VOLTAREN 94 81 82 109
SYMBICORT 92 51 83 149
AMITRIPTYLINE HCL 92 78 R 83 178
ENALAPRIL MALEATE 89 67 85 25
ENBREL 87 70 86 328
BENICAR HCT 83 70 87 133
ACTOS 82 76 88 112
VITAMIN D2 82 75 88 299
VICTOZA 2-PAK 81 48 90 393
LANTUS 77 64 91 66
HUMALOG 75 65 92 164
LEVOCETIRIZINE DIHYDROCHLORIDE 75 65 92 169
NIFEDIPINE ER 75 74 92 96
LEVEMIR FLEXPEN 75 63 92 188
NOVOLOG FLEXPEN 75 63 92 142
PRAVASTATIN SODIUM 73 58 97 18
OXYCODONE-ACETAMINOPHEN 73 55 S2 97 40
CLOTRIMAZOLE-BETAMETHASONE 73 42 97 91
HYDROXYCHLOROQUINE SULFATE 73 56 97 274
MUPIROCIN 73 51 97 117
IBUPROFEN 71 28 102 73
DILTIAZEM 24HR ER 69 54 103 176
MELOXICAM 69 46 103 49
BYETTA 67 40 105 369
COREG CR 67 64 105 313
HYDROCHLOROTHIAZIDE 66 49 107 12
TOPIRAMATE 65 12 108 199
CIPROFLOXACIN HCL 65 51 108 81
ISOSORBIDE MONONITRATE ER 64 64 110 57
RANEXA 63 46 111 323
CILOSTAZOL 62 49 112 204
BYDUREON 62 45 112 398
ESCITALOPRAM OXALATE 60 50 114 46
CARTIA XT 58 58 115 491
LACTULOSE 58 51 115 65
HYDRALAZINE HCL 56 46 117 89
AMMONIUM LACTATE 56 40 117 185
RISPERIDONE 55 54 119 56
PROCRIT 55 40 119 271
RANITIDINE HCL 55 39 119 80
TRAZODONE HCL 54 45 122 72
LEVOFLOXACIN 54 37 122 70
ENOXAPARIN SODIUM 53 49 124 173
MIRTAZAPINE 51 44 125 43
NASONEX 51 39 125 194
COLCRYS 50 48 127 230
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.